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在发展中国家及发达国家均有流行。HEV 的 4 个基因型根据流行病学和易感宿
主的差异可以分为两大类：一类为 H 类（Human），包括 HEV-1 和 HEV-2，主要





（ ORF2）的肽段（aa368-606）基因，并且利用大肠杆菌系统得到重组 D66 蛋
白。重组 D66 蛋白在水相中以二聚体为基本单位自组装成分子半径约为 13nm 的
颗粒。该颗粒与 HEV 感染的急性期、恢复期患者的血清均有较强的反应性。将
D66 颗粒与细胞共孵育，发现该颗粒可以与肝实质细胞系 HepG2 的细胞结合并
进入细胞内，这种结合可被恢复期及急性期 HEV 患者血清所阻断。这些结果表
明重组 D66 蛋白颗粒，可以一定程度上模拟 HEV-4 的表面位点，并且可以特异
性吸附并进入细胞，为进一步研究 HEV-4 感染的分子机制提供基础和平台。 
随后的研究中，我们通过 Western blot、ELISA 对实验室制备的多株抗 HEV-1
单抗进行筛选，获得了一株只与 HEV-1 反应的特异性抗体 2C9。接着，以 D66
为抗原，通过 D66 和 p239 共同筛选得到了 44 株 HEV-4 特异性抗体。条带 Western 
blot 结果显示，除了 8E9 外其余 43 株抗体与 D66 二聚体和单体都有反应性，筛
选得到的抗体以线性抗体居多。利用抗体阻断实验对以上 44 株抗体的表位进行
研究，这些抗体的表位较为分散，而且只有少部分与 HEV-1aa394-606 表位重叠。
筛选得到的型特异性抗体为 1、4 型差异的研究奠定了基础。 
本研究在体外传代的人源肝细胞系上检测了 1、4 型 HEV 重组蛋白的分布差
异。结果显示，8h 后 p239 与 D66 在胞内的分布存在差异，前者均匀分布在细胞
质中，而后者主要分布在细胞核周围。同时，在不同来源的新鲜肝脏（成人、胚


















都可以特异的吸附其他三种肝脏组织，但是 p239 和 D66 在这些组织上的分布有
明显差异。 
此外，本研究还在体外传代的人源肝细胞系上检测了 1、4 型 HEV 重组蛋白
相互间对细胞吸附的影响，结果显示 4 型重组蛋白 D66 可以阻断 1 型重组蛋白
p239 对 HepG2 细胞的吸附，而 p239 却不能阻断 D66 吸附细胞。对上述结果我
们也在 wtHEV 上做了进一步的验证。实验结果表明 p239 及 D66 可以阻断 HEV-1
吸附细胞，与上述结果相符。综合以上结果，本研究建立的 4 型 HEV 感染模型、
筛选得到 1/4 型 HEV 特异性抗体以及对 1、4 型 HEV 差异进行初步研究，为 HEV




















Hepatitis E (HE) is an acute hepatitis caused by Hepatitis E Virus (HEV), which 
is prevalent in developing countries, as well as developed countries.  Four genotypes 
of HEV were divided into two groups by their differences in epidemiology and 
susceptible host: the first is H group, including HEV-1 and HEV-2, which mainly 
infected human but none of other animals; the other is Z group, including HEV-3 and 
HEV-4, which existed generally in human, swine and other animals. The predominant 
strains in China are HEV-1 and HEV-4. More and more studies suggest that HEV 
could be transmitted to human by cross-infection between human and animals, which 
means that HE is a serious threat for human health. Because of limited source of 
nature virus and the lack of effective cell culture model, molecular mechanisms of 
HEV infection and replication are undiscovered.  And an infection model of HEV 
was developed in this study, then the differences between HEV-1 and HEV-4 was 
studied. 
At the beginning, the gene of ORF2 of HEV-4 (aa368-606) was obtained from 
pig bile, then recombinant protein D66 was expressed in E.coli., which spontaneously 
formed particles with a radius of 13nm based on D66 dimers. The particles reacted 
strongly with serum collected from HE patients at acute infection phase and 
convalescence phase. Also, D66 could adhere to and then enter HepG2 cells when 
incubated with the latter, but the adherence could be blocked by serum collected from 
HE patients at acute infection phase and convalescence phase. These results indicate 
that D66 particles could mimic the surface of HEV-4 virions and therefore could 
specifically adhere to and enter HepG2 cells, which is a suitable platform for further 
study of molecular mechanisms of HEV-4 infection. 
In the following study, several anti-HEV-1 antibodies were screened by Western 
blot and ELISA and a specific antibody (2C9) which only could react with HEV-1 was 
found. Then, 44 antibodies obtained from mice immured with D66 which were 
specific to HEV-4 were found by coated D66 and p239. And results obtained from 
stripping western blot showed that all of these antibodies but 8E9 could react with 
D66 monomers or dimmers, therefore most of them are against linear epitopes.  Then, 

















indicated that their epitopes were kind of scattered and only few of them were 
overlapping with HEV-1 epitopes located in aa394-606. These type-specific 
antibodies laid a good foundation for our study of the differences between type 1/4 
HEV. 
P239 and D66 were used to study the differences between type 1/4 HEV: after 
incubation with HepG2 cells for 8h, p239 was found to be evenly distributed in the 
cytoplasm by IF, while D66 was around the nucleus. Then, p239 and D66 were 
incubated with liver tissues of different origin (human, mice, embryo and swine) and 
both could specifically adhere to all tissues but tissues from mice, however, the 
distribution of the two proteins in these tissues was significantly different. Afterwards, 
one of p239 and D66 was incubated with certain cells, then another was added, results 
indicated that D66 could block p239’ adherence to cells while p239 couldn’t block 
D66’s adherence. 
In sum, all of these results confirmed that there are differences between type 1/4 
HEV in their infection with cells and specific antibodies against both virions lay a 
good foundation for the study of these differences. 
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一 戊型肝炎及戊型肝炎病毒概况  
1. 戊型肝炎概况 
戊型肝炎（Hepatitis E，HE），曾经被称为肠道传播的急性传染性非甲非乙
型肝炎（Enterically Transmitted Non-A Non-B Hepatitis, ET-NANBH ）。首次文献
报道的戊型肝炎流行发生于 19 世纪 50 年代的印度新德里，当时发现有 29000




（Hepatitis E Virus，HEV），同时建立检测 HEV 的酶联免疫吸附测定方法[4-6]。 
 
图 1 戊型肝炎病毒的地理分布 





































Bradley 等，1987 年通过免疫电镜观察到 HEV 是由病毒蛋白和 RNA 组成的
小 RNA 病毒，无包膜，大小约 27-34nm 的球形颗粒，其表面有许多类似于杯状
病毒的突起和缺刻结构；有实心和空心两种，前者占 66%比例完整的天然 HEV
病毒颗粒，后者推测可能为有缺陷的 HEV 病毒颗粒[16]。（图 2 电镜观察图） 





















图 2 HEV 天然病毒颗粒的免疫电镜观察结果 
Fig2 Natural HEV particles visualized by ImmunoElectron Microscopy(IEM) 




[18]等，1991 年首次报道了 HEV 的全基因序列，其基因组为单股正链的
RNA，全长大约 7.2kb。5’端有 m7G 帽子结构，3’端有 poly(A)尾巴[19]。序列分




外的亚基因组 mRNA，大小分别为 3.7Kb 和 2.0Kb，均由基因组外的互补链产生，
同源性对应于基因组的 3’端。（图 3 HEV 不同型基因组结构） 
3.1 ORF1 
HEV ORF1 的序列与其他的正链 RNA 病毒，如风疹病毒等，具有很高的同
源性，如果以 ORF1 序列为分类标准，可以将 HEV 归入类 α 病毒超家族。ORF1
编码一个 1693 个氨基酸的多肽，包括病毒复制和加工所需的非结构蛋白。根据
保守结构域分析，ORF1 有多个酶活性区:(1)RNA 依赖的 RNA 聚合酶
（RNA-dependent RNA polymerase,RdRP）,位于多聚蛋白 C 端，能与 HEV 基因
组的 3’端 NCR 直接相互作用，并指导反义 RNA 链的合成；(2)RNA 螺旋酶
（helicase），能在基因复制和转录中解开 RNA 结构；(3)木瓜蛋白酶样的半胱氨

















转移酶（methyltransferase），位于多聚蛋白 N 端；(4)两个未知功能的 X 区和 Y
区[11, 18, 20]。在体外翻译系统，E.coli 及 HepG2 细胞中表达 ORF1 发现一个分子量
186KD 的大蛋白，并未见剪切过程[21]。将体外转录的 HEV 全基因组 RNA 转染







图 3 不同型 HEV 基因组结构示意图 
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